Healthcare provider profile · identity verified

Jason Cooper, MD

Family Practice · BROWNSBURG, IN · NPI 1427131762

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	412	105
Amlodipine Besylate	Amlodipine Besylate	377	103
Levothyroxine Sodium	Levothyroxine Sodium	355	97
Simvastatin	Simvastatin	336	91
Rosuvastatin Calcium	Rosuvastatin Calcium	281	90
Metoprolol Succinate	Metoprolol Succinate	259	68
Omeprazole	Omeprazole	230	65
Lisinopril	Lisinopril	182	50
Metformin Hcl	Metformin Hcl	173	50
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	172	46
Losartan Potassium	Losartan Potassium	166	47
Tamsulosin Hcl	Tamsulosin Hcl	166	47
Gabapentin	Gabapentin	163	45
Pantoprazole Sodium	Pantoprazole Sodium	159	46
Duloxetine Hcl	Duloxetine Hcl	130	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	130	27
Potassium Chloride	Potassium Chloride	120	43
Hydrochlorothiazide	Hydrochlorothiazide	118	33
Pravastatin Sodium	Pravastatin Sodium	114	30
Meloxicam	Meloxicam	112	36
Alprazolam	Alprazolam	110	16
Metoprolol Tartrate	Metoprolol Tartrate	110	28
Sertraline Hcl	Sertraline Hcl	108	31
Trazodone Hcl	Trazodone Hcl	101	29
Citalopram Hbr	Citalopram Hydrobromide	99	29
Ozempic	Semaglutide	99	21
Allopurinol	Allopurinol	97	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	86	26
Clonazepam	Clonazepam	81	18
Warfarin Sodium	Warfarin Sodium	80	15
Fluticasone Propionate	Fluticasone Propionate	78	23
Zolpidem Tartrate	Zolpidem Tartrate	74	20
Fluoxetine Hcl	Fluoxetine Hcl	73	19
Tramadol Hcl	Tramadol Hcl	66	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	66	19
Metformin Hcl Er	Metformin Hcl	65	19
Clopidogrel	Clopidogrel Bisulfate	64	19
Albuterol Sulfate Hfa	Albuterol Sulfate	61	19
Furosemide	Furosemide	53	18
Ezetimibe	Ezetimibe	52	19
Atenolol	Atenolol	46	14
Carvedilol	Carvedilol	46	15
Montelukast Sodium	Montelukast Sodium	46	12
Fenofibrate	Fenofibrate Nanocrystallized	45	14
Hydroxyzine Hcl	Hydroxyzine Hcl	44	15
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	41	11
Escitalopram Oxalate	Escitalopram Oxalate	41	13
Klor-Con M20	Potassium Chloride	40	14
Synthroid	Levothyroxine Sodium	40	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	40	suppressed
Clonidine Hcl	Clonidine Hcl	34	suppressed
Famotidine	Famotidine	34	11
Fenofibrate	Fenofibrate	34	suppressed
Finasteride	Finasteride	34	suppressed
Glimepiride	Glimepiride	34	suppressed
Spironolactone	Spironolactone	34	suppressed
Bupropion Xl	Bupropion Hcl	33	suppressed
Eliquis	Apixaban	33	13
Azithromycin	Azithromycin	31	29
Buspirone Hcl	Buspirone Hcl	30	suppressed
Eszopiclone	Eszopiclone	29	suppressed
Prednisone	Prednisone	29	15
Valsartan	Valsartan	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Enalapril Maleate	Enalapril Maleate	26	suppressed
Cefdinir	Cefdinir	24	24
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Diazepam	Diazepam	22	suppressed
Methylprednisolone	Methylprednisolone	22	20
Valacyclovir	Valacyclovir Hcl	22	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Jardiance	Empagliflozin	21	suppressed
Ramipril	Ramipril	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Temazepam	Temazepam	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Estradiol	Estradiol	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Dilt-Xr	Diltiazem Hcl	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Zaleplon	Zaleplon	12	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error